INTRODUCTION: Cryopreserved allograft heart valves (CAHV) show longer event-free survival compared to other types of protheses. However, all patients develop early and/or late allograft failure. Negative predictors are clinical, and there is a lack of evidence whether they correspond with the microscopic structure of CAHV. We assessed histopathological signs of structural degeneration, degree of cellular preservation, and presence of antigen-presenting cells (APC) in CAHV and correlated the changes with donor clinical characteristics, cryopreservation times, and CAHV types and diameters. METHODS: Fifty-seven CAHV (48 pulmonary, nine aortic) used for transplantation between November/2017 and May/2019 were included. Donor variables were age, gender, blood group, height, weight, and body surface area (BSA). Types and diameters of CAHV, cold ischemia time, period from decontamination to cryopreservation, and cryopreservation time were recorded. During surgery, arterial wall (n=56) and valvar cusp (n=20) samples were obtained from the CAHV and subjected to microscopy. Microscopic structure was assessed using basic staining methods and immunohistochemistry (IHC). RESULTS: Most of the samples showed signs of degeneration, usually of mild degree, and markedly reduced cellular preservation, more pronounced in aortic CAHV, correlating with arterial APC counts in both basic staining and IHC. There was also a correlation between the degree of degeneration of arterial samples and age, height, weight, and BSA of the donors. These findings were independent of preservation times. CONCLUSION: CAHV show markedly reduced cellular preservation negatively correlating with the numbers of APC. More preserved CAHV may be therefore prone to stronger immune rejection.

Children's Heart Centre 2nd Faculty of Medicine Charles University and Motol University Hospital Praha Czech Republic

Clinical and Transplant Pathology Centre Institute for Clinical and Experimental Medicine Praha Czech Republic

Department of Cardiovascular Surgery 2nd Faculty of Medicine Charles University and Motol University Hospital Praha Czech Republic

Department of Pathology and Molecular Medicine 3rd Faculty of Medicine Charles University and Thomayer Hospital Praha Czech Republic

Department of Probability and Mathematical Statistics Faculty of Mathematics and Physics Charles University Praha Czech Republic

Department of Transplantation and Tissue Bank National Allograft Heart Valve Bank 2nd Faculty of Medicine Charles University and Motol University Hospital Praha Czech Republic

Zobrazit více v PubMed

Corno FA. Valved Conduits right ventricle to pulmonary artery for complex congenital heart defects. In: Cagini L, editor. Current Concepts in General Thoracic Surgery. 5. London: IntechOpen; 2012. DOI

Albert JD, Bishop DA, Fullerton DA, Campbell DN, Clarke DR. Conduit reconstruction of the right ventricular outflow tract. Lessons learned in a twelve-year experience. J Thorac Cardiovasc Surg. 1993;106(2):228–35. discussion 235-6. PubMed

Bielefeld MR, Bishop DA, Campbell DN, Mitchell MB, Grover FL, Clarke DR. Reoperative homograft right ventricular outflow tract reconstruction. Ann Thorac Surg. 2001;71(2):482–7. doi: 10.1016/s0003-4975(00)02521-2. discussion 487-8. PubMed DOI

Tweddell JS, Pelech AN, Frommelt PC, Mussatto KA, Wyman JD, Fedderly RT, et al. Factors affecting longevity of homograft valves used in right ventricular outflow tract reconstruction for congenital heart disease. Circulation. 2000;102(19 Suppl 3):III130–5. PubMed

Niwaya K, Knott-Craig CJ, Lane MM, Chandrasekaren K, Overholt ED, Elkins RC. Cryopreserved homograft valves in the pulmonary position: risk analysis for intermediate-term failure. J Thorac Cardiovasc Surg. 1999;117(1):141–6. doi: 10.1016/s0022-5223(99)70479-4. discussion 46-7. PubMed DOI

Baskett RJ, Ross DB, Nanton MA, Murphy DA. Factors in the early failure of cryopreserved homograft pulmonary valves in children: preserved immunogenicity? J Thorac Cardiovasc Surg. 1996;112(5):1170–8. discussion 1178-9. PubMed

Kalfa DM, Loundou A, Nouaille de Gorce Y, Fraisse A, Metras DR, Macé L, et al. Pulmonary position cryopreserved homograft in non-Ross patients: how to improve the results? Eur J Cardiothorac Surg. 2012;42(6):981–7. doi: 10.1093/ejcts/ezs248. PubMed DOI

Fiala R, Kochová P, Kubíková T, Cimrman R, Tonar Z, Špatenka J, et al. Mechanical and structural properties of human aortic and pulmonary allografts do not deteriorate in the first 10 years of cryopreservation and storage in nitrogen. Cell Tissue Bank. 2019;20(2):221–41. doi: 10.1007/s10561-019-09762-x. PubMed DOI

Spatenka J, Burkert J. In: Aortic regurgitation. Vojacek J, Zacek P, Dominik J, editors. Switzerland: Springer International; 2018. Valve allograft in aortic surgery; pp. 155–68.

Burkert J, Kochová P, Tonar Z, Cimrman R, Blassová T, Jashari R, et al. The time has come to extend the expiration limit of cryopreserved allograft heart valves. Cell Tissue Bank. 2021;22(2):161–84. doi: 10.1007/s10561-020-09843-2. PubMed DOI

Spatenka J, Honĕk T, Kostelka M, Hucín B, Fiser B, Hájek T, et al. [Harvesting the heart for preparation of heart valve allografts] Rozhl Chir. 1997;76(3):113–7. Czech. PubMed

Mosteller RD. Simplified calculation of body-surface area. N Engl J Med. 1987;317(17):1098. doi: 10.1056/NEJM198710223171717. PubMed DOI

Halushka MK, Angelini A, Bartoloni G, Basso C, Batoroeva L, Bruneval P, et al. Consensus statement on surgical pathology of the aorta from the society for cardiovascular pathology and the association for European cardiovascular pathology: II. Noninflammatory degenerative diseases - nomenclature and diagnostic criteria. Cardiovasc Pathol. 2016;25(3):247–57. doi: 10.1016/j.carpath.2016.03.002. PubMed DOI

Lisy M, Kalender G, Schenke-Layland K, Brockbank KG, Biermann A, Stock UA. Allograft heart valves: current aspects and future applications. Biopreserv Biobank. 2017;15(2):148–57. doi: 10.1089/bio.2016.0070. PubMed DOI

Kubíková T, Kochová P, Fiala R, Špatenka J, Burkert J, Králíčková M, et al. Histological composition and mechanical properties of cryopreserved samples of aortic and pulmonary valves. SSP. 2016;258:341–4. doi: 10.4028/www.scientific.net/ssp.258.341. DOI

Schenke-Layland K, Madershahian N, Riemann I, Starcher B, Halbhuber KJ, König K, et al. Impact of cryopreservation on extracellular matrix structures of heart valve leaflets. Ann Thorac Surg. 2006;81(3):918–26. doi: 10.1016/j.athoracsur.2005.09.016. PubMed DOI

Kano M, Masuda Y, Tominaga T, Hori T, Kitaichi T, Yoshizumi M, et al. Collagen synthesis and collagenase activity of cryopreserved heart valves. J Thorac Cardiovasc Surg. 2001;122(4):706–11. PubMed

Kitagawa T, Masuda Y, Tominaga T, Kano M. Cellular biology of cryopreserved allograft valves. J Med Invest. 2001;48(3-4):123–32. PubMed

Krs O, Slízová D, Burkert J, Spatenka J, Hottmar P. Impact of processing on surface structure of human cardiac valve allografts. Acta Medica (Hradec Kralove) 2004;47(2):97–9. PubMed

Burkert J, Krs O, Vojácek J, Mokrácek A, Slízová D, Hlubocký J, et al. Cryopreserved semilunar heart valve allografts: leaflet surface damage in scanning electron microscopy. Zentralbl Chir. 2008;133(4):367–73. doi: 10.1055/s-2008-1076872. PubMed DOI

Heacox AE, McNally RT, Brockbank KGM. Factors affecting the viability of cryopreserved allograft heart valves. In: Yankah AC, Hetzer R, Miller DC, Ross DN, Sommerville J, Yacoub MH, editors. Cardiac valve allografts 1962-1987. New York: Springer-Verlag; 1988. pp. 37–41.

Koolbergen DR, Hazekamp MG, de Heer E, Bruggemans EF, Huysmans HA, Dion RA, et al. The pathology of fresh and cryopreserved homograft heart valves: an analysis of forty explanted homograft valves. J Thorac Cardiovasc Surg. 2002;124(4):689–97. PubMed

Lupinetti FM, Christy JP, King DM, el Khatib H, Thompson SA. Immunogenicity, antigenicity, endothelial viability of aortic valves preserved at 4 degrees C in a nutrient medium. J Card Surg. 1991;6(4):454–61. doi: 10.1111/j.1540-8191.1991.tb00345.x. PubMed DOI

Yankah AC, Wottge HU, Muller-Hermelink HK, Feller AC, Lange P, Wessel U, et al. Transplantation of aortic and pulmonary allografts, enhanced viability of endothelial cells by cryopreservation, importance of histocompatibility. J Card Surg. 1987;2(1 Suppl):209–20. doi: 10.1111/jocs.1987.2.1s.209. PubMed DOI

Livi U, Abdulla AK, Parker R, Olsen EJ, Ross DN. Viability and morphology of aortic and pulmonary homografts. A comparative study. J Thorac Cardiovasc Surg. 1987;93(5):755–60. PubMed

da Costa FD, Takkenberg JJ, Fornazari D, Balbi Filho EM, Colatusso C, Mokhles MM, et al. Long-term results of the Ross operation: an 18-year single institutional experience. Eur J Cardiothorac Surg. 2014;46(3):415–22. doi: 10.1093/ejcts/ezu013. discussion 422. PubMed DOI